Published in Respir Res on December 21, 2012
Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clin Chem (2013) 1.67
Biomarkers of progression of chronic obstructive pulmonary disease (COPD). J Thorac Dis (2014) 1.14
Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath. Metabolites (2015) 1.03
Evaluation of Chemical Interactions between Small Molecules in the Gas Phase Using Chemical Force Microscopy. Sensors (Basel) (2015) 0.88
Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers. Lung (2014) 0.87
Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview. Metabolites (2015) 0.87
Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. BMC Pulm Med (2014) 0.85
Trends in Nanomaterial-Based Non-Invasive Diabetes Sensing Technologies. Diagnostics (Basel) (2014) 0.83
Single-carbon discrimination by selected peptides for individual detection of volatile organic compounds. Sci Rep (2015) 0.82
Exhaled breath profiling for diagnosing acute respiratory distress syndrome. BMC Pulm Med (2014) 0.78
Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects. Int J Chron Obstruct Pulmon Dis (2015) 0.78
Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects. Lung Cancer (Auckl) (2017) 0.77
Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns. Sensors (Basel) (2016) 0.77
Fusing Sensor Paradigms to Acquire Chemical Information: An Integrative Role for Smart Biopolymeric Hydrogels. Adv Healthc Mater (2016) 0.76
Gas-phase broadband spectroscopy using active sources: progress, status, and applications. J Opt Soc Am B (2016) 0.75
Nanostructured Polypyrrole-Based Ammonia and Volatile Organic Compound Sensors. Sensors (Basel) (2017) 0.75
Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer. PLoS One (2017) 0.75
Lung Cancer Screening Based on Type-different Sensor Arrays. Sci Rep (2017) 0.75
BreathDx - molecular analysis of exhaled breath as a diagnostic test for ventilator-associated pneumonia: protocol for a European multicentre observational study. BMC Pulm Med (2017) 0.75
Pattern recognition for predictive, preventive, and personalized medicine in cancer. EPMA J (2017) 0.75
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry. PLoS One (2017) 0.75
Screening of Obstructive Sleep Apnea Syndrome by Electronic-Nose Analysis of Volatile Organic Compounds. Sci Rep (2017) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol (2009) 17.92
Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J (2008) 10.08
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet (1999) 3.70
Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol (2009) 3.16
Detection of lung cancer with volatile markers in the breath. Chest (2003) 3.09
Detection of lung cancer by sensor array analyses of exhaled breath. Am J Respir Crit Care Med (2005) 2.94
Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron (2003) 2.72
Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer (2010) 2.35
Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax (2009) 2.28
Diagnostic potential of breath analysis--focus on volatile organic compounds. Clin Chim Acta (2004) 2.12
Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med (2009) 2.12
Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer (2009) 1.99
An investigation on electronic nose diagnosis of lung cancer. Lung Cancer (2009) 1.85
Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem (1985) 1.83
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer (2008) 1.80
Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Respir Res (2005) 1.68
Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med (2009) 1.64
Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark (2007) 1.60
Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb) (2006) 1.57
Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr (2007) 1.56
Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax (2007) 1.54
Application of a new method for analysis of exhaled gas in critically ill patients. Intensive Care Med (1998) 1.53
Application of laser spectroscopy for measurement of exhaled ethane in patients with lung cancer. Respir Med (2005) 1.48
An electronic nose in the discrimination of patients with asthma and controls. J Allergy Clin Immunol (2007) 1.40
Breath gas aldehydes as biomarkers of lung cancer. Int J Cancer (2010) 1.38
Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study. Thorax (2010) 1.37
Breath biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb) (2010) 1.31
Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. J Chromatogr (1988) 1.28
The scent of Mycobacterium tuberculosis--part II breath. Tuberculosis (Edinb) (2009) 1.27
Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 1.21
Quantitative breath analysis of volatile organic compounds of lung cancer patients. Lung Cancer (2009) 1.21
Detection of lung cancer using weighted digital analysis of breath biomarkers. Clin Chim Acta (2008) 1.21
A breath test for malignant mesothelioma using an electronic nose. Eur Respir J (2011) 1.21
Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol (2012) 1.19
Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res (2010) 1.16
Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatr Pulmonol (2009) 1.13
Sniffing out the truth: clinical diagnosis using the electronic nose. Clin Chem Lab Med (2000) 1.13
A profile of volatile organic compounds in breath discriminates COPD patients from controls. Respir Med (2009) 1.08
Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci U S A (2005) 1.08
Breath biomarkers for lung cancer detection and assessment of smoking related effects--confounding variables, influence of normalization and statistical algorithms. Clin Chim Acta (2010) 1.07
Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 1.06
Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. Med Mycol (2009) 1.06
Elevation of exhaled ethane concentration in asthma. Am J Respir Crit Care Med (2000) 1.05
Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings. Laryngoscope (2004) 1.04
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J (2011) 1.03
External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy (2011) 1.02
Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutants. J Breath Res (2012) 1.01
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. Chest (2010) 0.98
Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Eur Respir J (2006) 0.98
Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax (2011) 0.97
Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. Clin Exp Allergy (2009) 0.96
Exhaled pentane levels in acute asthma. Chest (1997) 0.94
Electronic nose prediction of a clinical pneumonia score: biosensors and microbes. Anesthesiology (2005) 0.94
Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics. J Chromatogr B Analyt Technol Biomed Life Sci (2011) 0.94
Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst (2010) 0.93
Integrated statistical learning of metabolic ion mobility spectrometry profiles for pulmonary disease identification. Genet Mol Res (2012) 0.92
Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb) (2012) 0.92
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls. Lung Cancer (2011) 0.92
Allergic asthma exhaled breath metabolome: a challenge for comprehensive two-dimensional gas chromatography. J Chromatogr A (2012) 0.91
Correlation of pneumonia score with electronic nose signature: A prospective study. Ann Otol Rhinol Laryngol (2005) 0.91
Exhaled ethane: an in vivo biomarker of lipid peroxidation in interstitial lung diseases. Chest (2005) 0.91
Identification of volatile lung cancer markers by gas chromatography-mass spectrometry: comparison with discrimination by canines. Anal Bioanal Chem (2012) 0.91
Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom (2011) 0.90
Breath analysis as a potential diagnostic tool for tuberculosis. Int J Tuberc Lung Dis (2012) 0.90
Breath analysis in non small cell lung cancer patients after surgical tumour resection. Acta Biomed (2008) 0.89
Determination of ethane, pentane and isoprene in exhaled air--effects of breath-holding, flow rate and purified air. Acta Physiol (Oxf) (2007) 0.88
Screening for emphysema via exhaled volatile organic compounds. J Breath Res (2011) 0.87
Breath markers and soluble lipid peroxidation markers in critically ill patients. Clin Chem Lab Med (2002) 0.87
The application of statistical methods using VOCs to identify patients with lung cancer. J Breath Res (2011) 0.85
An investigation of suitable bag materials for the collection and storage of breath samples containing hydrogen cyanide. J Breath Res (2012) 0.85
Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose. Respirology (2011) 0.85
Machine learning methods on exhaled volatile organic compounds for distinguishing COPD patients from healthy controls. J Breath Res (2012) 0.85
Detection of gastro-oesophageal reflux disease (GORD) in patients with obstructive lung disease using exhaled breath profiling. J Breath Res (2012) 0.84
Chemical characterization of exhaled breath to differentiate between patients with malignant plueral mesothelioma from subjects with similar professional asbestos exposure. Anal Bioanal Chem (2010) 0.83
Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology. J Chromatogr A (2011) 0.82
Decline of exhaled isoprene in lung cancer patients correlates with immune activation. J Breath Res (2012) 0.81
Exhaled pentane as a possible marker for survival and lipid peroxidation during radiotherapy for lung cancer--a pilot study. Free Radic Res (2009) 0.81
Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. Am J Respir Crit Care Med (2000) 0.80
Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders. J Chromatogr A (2008) 0.80
An off-line breath sampling and analysis method suitable for large screening studies. Physiol Meas (2007) 0.79
Breath isoprene during acute respiratory exacerbation in cystic fibrosis. Eur Respir J (2000) 0.79
Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin Immunol (2011) 2.39
Effect of smoke-free legislation on the incidence of sudden circulatory arrest in the Netherlands. Heart (2012) 2.10
Interactive effect of family history and environmental factors on respiratory tract-related morbidity in infancy. J Allergy Clin Immunol (2007) 1.71
Novel strategies in newborn screening for cystic fibrosis: a prospective controlled study. Thorax (2012) 1.59
Discrepancy between functional exercise capacity and daily physical activity: a cross-sectional study in patients with mild to moderate COPD. Prim Care Respir J (2013) 1.46
Pain-related fear and daily functioning in patients with osteoarthritis. Pain (2004) 1.43
Prevention of asthma in genetically susceptible children: a multifaceted intervention trial focussed on feasibility in general practice. Pediatr Allergy Immunol (2011) 1.42
Environmental exposure reduction in high-risk newborns: where do we start? Ann Allergy Asthma Immunol (2003) 1.39
The impact of a primary care physician cooperative on the caseload of an emergency department: the Maastricht integrated out-of-hours service. J Gen Intern Med (2005) 1.26
Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res (2010) 1.16
Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Addiction (2014) 1.15
Out-of-hours primary care. Implications of organisation on costs. BMC Fam Pract (2006) 1.13
Treatment with a nicotine vaccine does not lead to changes in brain activity during smoking cue exposure or a working memory task. Addiction (2014) 1.10
Instructiveness of real patients and simulated patients in undergraduate medical education: a randomized experiment. Acad Med (2010) 1.06
Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments. Prim Care Respir J (2013) 1.05
Follow-up care by patient's own general practitioner after contact with out-of-hours care. A descriptive study. BMC Fam Pract (2005) 0.99
Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol (2004) 0.97
Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma. Cochrane Database Syst Rev (2009) 0.96
Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study. BMC Public Health (2009) 0.95
Biomarkers in exhaled breath condensate indicate presence and severity of cystic fibrosis in children. Pediatr Allergy Immunol (2008) 0.93
What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD? Patient Educ Couns (2009) 0.90
Early detection of COPD in general practice: implementation, workload and socioeconomic status. A mixed methods observational study. Prim Care Respir J (2013) 0.90
The primary prevention of asthma in children study: design of a multifaceted prevention program. Pediatr Allergy Immunol (2005) 0.89
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis. Ann Allergy Asthma Immunol (2006) 0.88
Asthma education tailored to individual patient needs can optimise partnerships in asthma self-management. Patient Educ Couns (2002) 0.88
Feasibility of a new method to collect exhaled breath condensate in pre-school children. Pediatr Allergy Immunol (2009) 0.87
The changing role of self-efficacy in adolescent smoking initiation. J Adolesc Health (2010) 0.87
Population impact of reimbursement for smoking cessation: a natural experiment in The Netherlands. Addiction (2012) 0.87
Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma. Ann Allergy Asthma Immunol (2008) 0.86
Intestinal lactobacilli and the DC-SIGN gene for their recognition by dendritic cells play a role in the aetiology of allergic manifestations. Microbiology (2010) 0.86
Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study. Eur Respir J (2013) 0.86
Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial. BMC Public Health (2010) 0.86
Exhaled breath condensate in children: pearls and pitfalls. Pediatr Allergy Immunol (2004) 0.85
Host-microbial interactions in childhood atopy: toll-like receptor 4 (TLR4), CD14, and fecal Escherichia coli. J Allergy Clin Immunol (2010) 0.84
Actual asthma control in a paediatric outpatient clinic population: do patients perceive their actual level of control? Pediatr Allergy Immunol (2008) 0.84
Validation of the COPD Diagnostic Questionnaire in an Australian general practice cohort: a cross-sectional study. Prim Care Respir J (2014) 0.84
Structural lung changes, lung function, and non-invasive inflammatory markers in cystic fibrosis. Pediatr Allergy Immunol (2010) 0.84
A systematic review of CD14 and toll-like receptors in relation to asthma in Caucasian children. Allergy Asthma Clin Immunol (2013) 0.84
Smoking-specific parenting and smoking onset in adolescence: the role of genes from the dopaminergic system (DRD2, DRD4, DAT1 genotypes). PLoS One (2013) 0.83
Willingness of patients to perform self-management of asthma and the role of inhaled steroids. Scand J Prim Health Care (2002) 0.83
Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: results of a randomised controlled trial. BMJ Open (2012) 0.83
Effectiveness of the Assessment of Burden of Chronic Obstructive Pulmonary Disease (ABC) tool: study protocol of a cluster randomised trial in primary and secondary care. BMC Pulm Med (2014) 0.83
Smoking-specific communication and children's smoking onset: an extension of the theory of planned behaviour. Psychol Health (2012) 0.83
Sex differences in the relationship between asthma and overweight in Dutch children: a survey study. PLoS One (2013) 0.83
Patient preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: results of a randomised controlled trial. Int J Nurs Stud (2013) 0.82
Smoking cessation and development of respiratory health in smokers screened with normal spirometry. Respir Med (2010) 0.82
Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial. BMC Pulm Med (2014) 0.82
Intact IFN-γR1 expression and function distinguishes Langerhans cell histiocytosis from mendelian susceptibility to mycobacterial disease. J Clin Immunol (2013) 0.82
Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age. Am J Respir Crit Care Med (2015) 0.82
Course length of 30 metres versus 10 metres has a significant influence on six-minute walk distance in patients with COPD: an experimental crossover study. J Physiother (2013) 0.81
Do We Need Tailored Smoking Cessation Interventions for Smokers with COPD? A Comparative Study of Smokers with and without COPD Regarding Factors Associated with Tobacco Smoking. Respiration (2015) 0.81
Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study. Int J Integr Care (2012) 0.81
A motivational interviewing intervention to PREvent PAssive Smoke Exposure (PREPASE) in children with a high risk of asthma: design of a randomised controlled trial. BMC Public Health (2013) 0.81
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial. BMC Public Health (2012) 0.81
Interpreting the diagnostic accuracy of tools for early detection of COPD. Prim Care Respir J (2011) 0.80
To know or not to know, disclosure of a newborn carrier screening test result for cystic fibrosis. Eur J Med Genet (2013) 0.79
Free radicals in exhaled breath condensate in cystic fibrosis and healthy subjects. Free Radic Res (2006) 0.79
Wheezing in preschool children is associated with increased levels of cytokines/chemokines in exhaled breath condensate. J Allergy Clin Immunol (2010) 0.79
Patterns of inflammation and the use of reversibility testing in smokers with airway complaints. BMC Pulm Med (2006) 0.79
Efficacy of smoking prevention program 'Smoke-free Kids': study protocol of a randomized controlled trial. BMC Public Health (2009) 0.79
The link between asthma and smoking explained by depressive feelings and self-efficacy. J Psychosom Res (2013) 0.78
Exhaled breath profiling in diagnosing wheezy preschool children. Eur Respir J (2013) 0.78
Cost-effectiveness of early assisted discharge for COPD exacerbations in The Netherlands. Value Health (2013) 0.78
An Online Health Prevention Intervention for Youth with Addicted or Mentally Ill Parents: Experiences and Perspectives of Participants and Providers from a Randomized Controlled Trial. J Med Internet Res (2015) 0.78
Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children. BMC Med Res Methodol (2011) 0.78
Multifactorial intervention for children with asthma and overweight (Mikado): study design of a randomised controlled trial. BMC Public Health (2013) 0.78
Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma. Pediatr Allergy Immunol (2014) 0.78
Longitudinal associations between asthma control, medication adherence, and quality of life among adolescents: results from a cross-lagged analysis. Qual Life Res (2015) 0.78
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial. BMC Public Health (2007) 0.78
Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study. Int J Chron Obstruct Pulmon Dis (2009) 0.78
How do dyspnoea scales compare with measurement of functional capacity in patients with COPD and at risk of COPD? Prim Care Respir J (2012) 0.78
Elevated inflammatory markers at preschool age precede persistent wheezing at school age. Pediatr Allergy Immunol (2011) 0.77
Feasibility of exhaled nitric oxide measurements at various flow rates in children with asthma. Pediatr Allergy Immunol (2010) 0.77
Sport club participation of adolescents with asthma: maternal factors and adolescent cognitions. Pediatr Pulmonol (2013) 0.77